title: JAK2V617F allele burden is reduced by busulfan therapy: a new observation using an old drug.
authors.affiliation: rtsilve@med.cornell.edu.
authors.forename: Emil T
authors.initials: ET
authors.lastname: Kuriakose
authors.forename: Stefani
authors.initials: S
authors.lastname: Gjoni
authors.forename: Y Lynn
authors.initials: YL
authors.lastname: Wang
authors.forename: Ruth
authors.initials: R
authors.lastname: Baumann
authors.forename: Amy V
authors.initials: AV
authors.lastname: Jones
authors.forename: Nicholas C P
authors.initials: NC
authors.lastname: Cross
authors.forename: Richard T
authors.initials: RT
authors.lastname: Silver
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D000483:Alleles; D002066:Busulfan / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D053614:Janus Kinase 2 / Q000235:genetics*; D008297:Male; D019653:Myeloablative Agonists / Q000627:therapeutic use*; D011087:Polycythemia Vera / Q000188:drug therapy* / Q000235:genetics*
chemical_list: D019653:Myeloablative Agonists; C507924:JAK2 protein, human; D053614:Janus Kinase 2; D002066:Busulfan
keywords: AML/MDS; PV; busulfan; polycythemia vera